Featured

Median Technologies Submits 510(k) Application for eyonis® LCS Lung Cancer Screening SaMD

Median Technologies announced the submission of a 510(k) application to the FDA for eyonis® LCS, an AI-powered software as a medical device (SaMD) for...

Home/KnolSights/Regulatory Approvals/Median Technologies Submits 510(k) Application for eyonis® LCS Lung Cancer Screening SaMD